mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-05 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
1e-05 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
1e-05 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.28 |
1e-05 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
1e-05 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
1e-05 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
2e-05 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
2e-05 |